Clustering data with hclust algorithm for (Study ST004296)

(Analysis AN007142)
MetaboliteStructureF1F2
Sphinganine_positive_modeME11660700.551.30
Sphingosine_positive_modeME11660711.410.73
Docosanamide_positive_modeME11660801.090.94
TG(14:0/O-18:0/20:3(5Z,8Z,11Z))_positive_modeME11660721.070.95
Cer(d18:1/24:1(15Z))_positive_modeME11660581.120.92
PC(O-14:0/16:0)_positive_modeME11660651.120.92
CL(16:0/16:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))_positive_modeME11660751.110.93
LysoPC(18:0/0:0)_positive_modeME11660621.110.93
Cer(d18:2/25:0)_positive_modeME11660601.160.89
Cer(d18:1/22:1(13Z))_positive_modeME11660571.140.91
PC(P-16:0/14:0)_positive_modeME11660841.140.91
PI(18:0/20:3(8Z,11Z,14Z))_positive_modeME11660861.300.80
LysoPE(P-18:0/0:0)_positive_modeME11660831.180.88
Cer(d18:2/23:0)_positive_modeME11660591.190.87
DG(14:0/24:1(15Z)/0:0)_positive_modeME11660771.190.87
SM(d18:0/16:1(9Z))_positive_modeME11660681.220.85
PI(16:0/20:4(8Z,11Z,14Z,17Z))_positive_modeME11660671.240.84
SM(d18:1/17:0)_positive_modeME11660691.250.84
LysoPE(20:0/0:0)_positive_modeME11660821.020.99
PE(P-16:0/22:1(13Z))_positive_modeME11660851.030.98
Coenzyme Q10_positive_modeME11660761.040.98
PC(O-14:0/16:1(9Z))_positive_modeME11660661.040.97
CE(20:5(5Z,8Z,11Z,14Z,17Z))_positive_modeME11660560.981.01
TG(24:1(15Z)/15:0/18:2(9Z,12Z))_positive_modeME11660880.971.02
TG(i-16:0/10:0/19:0)_positive_modeME11660730.971.02
LysoPC(20:0/0:0)_positive_modeME11660640.961.02
DG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)_positive_modeME11660790.961.03
CL(16:0/16:0/18:0/20:4(5Z,8Z,11Z,14Z))_positive_modeME11660610.961.03
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-22:0/0:0)_positive_modeME11660780.961.03
Cer(d18:0/26:0)_positive_modeME11660740.801.13
LysoPC(18:1(11Z)/0:0)_positive_modeME11660630.781.15
LysoPC(20:1(11Z)/0:0)_positive_modeME11660810.901.06
TG(14:0/15:0/24:0)_positive_modeME11660870.871.08

Factors:

F1Sample source:hASCs | Treatment:Osteogenic conditions
F2Sample source:hASCs | Treatment:Proliferation conditions
Data matrix
  logo